Intrapulmonic Cavity or Necrosis on Baseline CT Scan Serves as an Efficacy Predictor of Anti-PD-(L)1 Inhibitor in Advanced Lung Squamous Cell Carcinoma

por Lu, Tao, Zhang, Longfeng, Chen, Mingqiu, Zheng, Xiaobin, Jiang, Kan, Zheng, Xinlong, Li, Chao, Xiao, Weijin, Miao, Qian, Yang, Shanshan, Lin, Gen
Publicado 2021

Heterogeneity of tumor immune microenvironment and real-world analysis of immunotherapy efficacy in lung adenosquamous carcinoma

por Li, Chao, Zheng, Xiaobin, Li, Pansong, Wang, Huijuan, Hu, Jie, Wu, Lin, Wang, Zhijie, Guo, Hui, Wu, Fang, Zhong, Wenzhao, Zhou, Chengzhi, Chu, Qian, Zhao, Jun, Zheng, Xinlong, Xiao, Weijin, Zhu, Weifeng, Zhang, Longfeng, Li, Qian, Jiang, Kan, Miao, Qian, Wu, Biao, Xu, Yiquan, Wu, Shiwen, Wang, Haibo, Yang, Shanshan, Li, Yujing, Xia, Xuefeng, Yi, Xin, Huang, Cheng, Zhu, Bo, Lin, Gen
Publicado 2022

CD8(+) T cell/cancer-associated fibroblast ratio stratifies prognostic and predictive responses to immunotherapy across multiple cancer types

por Zheng, Xinlong, Jiang, Kan, Xiao, Weijin, Zeng, Dongqiang, Peng, Wenying, Bai, Jing, Chen, Xiaohui, Li, Pansong, Zhang, Longfeng, Zheng, Xiaobin, Miao, Qian, Wang, Haibo, Wu, Shiwen, Xu, Yiquan, Xu, Haipeng, Li, Chao, Li, Lifeng, Gao, Xuan, Zheng, Suya, Li, Junhui, Wang, Deqiang, Zhou, Zhipeng, Xia, Xuefeng, Yang, Shanshan, Li, Yujing, Cui, Zhaolei, Zhang, Qiuyu, Chen, Ling, Lin, Xiandong, Lin, Gen
Publicado 2022